Nanoparticle-Based gene therapy strategies in retinal delivery

Thomas Foster, Patrick Lim, Susbin Raj Wagle, Corina Mihaela Ionescu, Bozica Kovacevic, Samuel McLenachan, Livia Carvalho, Alicia Brunet, Armin Mooranian, Hani Al-Salami

Research output: Contribution to journalReview articlepeer-review

Abstract

Vision loss and blindness are significant issues in both developed and developing countries. There are a wide variety of aetiologies that can cause vision loss, which are outlined in this review. Although treatment has significantly improved over time for some conditions, nearly half of all people with vision impairment are left untreated. Gene delivery is an emerging field that may assist with the treatment of some of these difficult to manage forms of vision loss. Here we review how a component of nanotechnology-based, non-viral gene delivery systems are being applied to help resolve vision impairment. This review focuses on the use of lipid and polymer nanoparticles, and quantum dots as gene delivery vectors to the eye. Finally, we also highlight some emerging technologies that may be useful in this discipline.

Original languageEnglish
Pages (from-to)508-527
Number of pages20
JournalJournal of Drug Targeting
Volume33
Issue number4
Early online date3 Jan 2025
DOIs
Publication statusPublished - 2025

Fingerprint

Dive into the research topics of 'Nanoparticle-Based gene therapy strategies in retinal delivery'. Together they form a unique fingerprint.

Cite this